Skip to main content
Fig. 4 | Cancer Cell International

Fig. 4

From: Down-regulation of miR-29c is a prognostic biomarker in acute myeloid leukemia and can reduce the sensitivity of leukemic cells to decitabine

Fig. 4

MiR-29c increased sensitivity to DAC and promoted apoptosis in DAC-resistant leukemic cells. a CCK-8 Kit analysis the cell viability in K562/DAC-NC and K562/DAC-miR-29c cells. b, c Analysis the sensitive of DAC in K562/DAC-NC and K562/DAC-miR-29c cells by CCK-8 Kit. d The statistical analysis of flow cytometry about K562/DAC-NC and K562/DAC-miR-29c cells cells. The IC50 was the half maximal inhibitory concentration

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us